Stand Up To Cancer


The latest, greatest story about the fight against melanoma has come from Stand Up To Cancer…take a few minutes to watch this, and when you read below why we started baking Love Bars and working toward this cause, you’ll understand how excited we are that each of you, our customers,  are a part of this BIG discovery:  click here


Our friend Kris, who fought a very tough battle with Stage IV Melanoma, passed away on December 22, 2011.  She was a loving mother to her 11-year-old daughter, and a wonderful friend to so many of us.  We hold her in our hearts, forever.

A Cause for Kris was our original charitable campaign, and thanks to so very many of you, we were able to help Kris and her daughter with some medical bills and other needs.  The family is so grateful for all of your help…it has made a difference at such a difficult time.  Thank you so much to all of you who purchased Love Bars and fudge throughout the year and over the holidays.

In keeping with this important cause, we decided to donate 25 cents from every Love Bar sale to Stand Up To Cancer, which started a dream team for melanoma treatment.  It is our hope that their research will help those diagnosed with advanced stage melanoma, like Kris, in the future.



Stand Up To Cancer


The New SU2C and Melanoma Research Alliance Dream Team

Today, Stand Up To Cancer, the Melanoma Research Alliance (MRA) and SU2C’s scientific partner, the American Association for Cancer Research (AACR), are proud to announce a new Dream Team dedicated to melanoma research. The Dream Team project, led by Jeffrey M. Trent, Ph.D. and Patricia M. LoRusso, D.O., marks the first collaborative Dream Team between SU2C and the MRA.

Currently, there are more than 70,000 new cases of melanoma reported each year in the United States, and more than 8,000 deaths annually. This new team will pursue targeted therapies for patients with a melanoma subtype for which there are currently few treatment options.

The Dream Team project entitled Personalized Medicine for Patients with BRAFWild-Type (BRAFwt) Cancer, will investigate the utility of personalized target/therapy identification in patients with BRAFwt metastatic melanoma. The team hopes that an individualized medicine approach to the treatment of BRAFwtmetastatic melanoma will not only lead to therapeutic benefit for this patient population, but may also be beneficial to many other tumor and disease types.

“Combining resources to compete against this disease and accelerating the pace of cancer research are twin pillars of the Stand Up To Cancer approach, and we were delighted to work with the Melanoma Research Alliance on our first grant made in collaboration with another foundation,” said Sherry Lansing, one of Stand Up To Cancer’s co-founders.

All of this would not be possible without the generous support of donors like you. With your help our Dream Teams and Innovative Grant Recipients are working hard to bring new treatments to patients faster. With more funding comes more Dream Teams like this one, that bring us one step closer to the end of cancer.

To learn more about this exciting new Dream Team and SU2C’s collaboration with the MRA click here!

Stand Up To Cancer


Stand Up To Cancer
1201 West 5th St., Ste. T-700, Los Angeles, CA, 90017